EUVIMEDEUVIMED entdecken
Crossref

Split proximity circuit initiated CRISPR-Cas12a system profiling exosomal surface proteins for early cancer detection

Weixue Xu, Yan Lin, Zena Huang, Yanyan Li, Yao Lu, Meiru Liu, Sicheng Cui, Tenghua Zhang, Nan Shi, Yan Sheng, Jiaming Hu

Biosensors and Bioelectronics · 2026-03 · 295 · 118280

DOI: 10.1016/j.bios.2025.118280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026-03. Verfasst von Weixue Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: International Joint Laboratory of Catalytic Chemistry, Innovation Institute of Carbon Neutrality, Department of Chemistry, College of Sciences, Shang…. Hauptthemen laut MEDLINE: Exosomes, CRISPR-Cas Systems, Biosensing Techniques, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Program key projects, National Key Research and Development Program of China, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early diagnosis of breast cancer is critical for improving prognosis, but traditional methods have limitations. Herein, we propose an SPC-CRISPR system for the sensitive and specific detection of multiple breast cancer exosomal proteins without prior exosome isolation. This system couples CRISPR system with an enzyme-free amplification method to achieve dual-signal amplification. SPC-CRISPR is based on a split proximity circuit (SPC) that triggers catalytic hairpin assembly (CHA), converting protein signals on the surface of exosomes into nucleic acid signals, and the CRISPR-Cas12a system enabling further signal amplification and output. The system targets phosphatidylserine (PS), MUC1, and EpCAM on exosomes: Tim4-modified magnetic beads capture PS-expressing exosomes, and dual-aptamers recognize MUC1 and EpCAM, enabling SPC assembly and subsequent amplification. In buffer and cell-derived exosomes, the SPC-CRISPR system showed a detection limit of 10 particles/μL (R2 = 0.990). Clinical tests utilizing merely 1 μL of serum samples successfully distinguished breast cancer patients from healthy donors (AUC = 0.9778, accuracy = 91.23 %), detected stage 0 breast cancer patients against healthy controls (accuracy = 92.59 %), and differentiated metastatic from non-metastatic cases (p < 0.001). The combination of high sensitivity, minimal sample requirements, and an exosome isolation-free workflow positions the SPC-CRISPR system as a promising tool for the clinical early detection and classification of breast cancer, with broader applicability to other cancers by swapping the corresponding aptamers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesCRISPR-Cas SystemsBiosensing TechniquesBreast NeoplasmsEarly Detection of CancerBiomarkers, TumorHumansFemaleEpithelial Cell Adhesion MoleculeLimit of DetectionMucin-1Aptamers, Nucleotide

Stichwörter der Autor:innen

CRISPR-Cas12aCancer detectionCatalytic hairpin assemblyExosomal surface proteinSplit proximity circuit

Substanzen

Epithelial Cell Adhesion MoleculeBiomarkers, TumorMucin-1MUC1 protein, humanEPCAM protein, humanAptamers, Nucleotide

Autor:innen und Institutionen

  • International Joint Laboratory of Catalytic Chemistry, Innovation Institute of Carbon Neutrality, Department of Chemistry, College of Sciences, Shanghai University, Shanghai, 200444, China.
  • Yunkang School of Medicine and Health, Nanfang College, Guangzhou, 510000, China.
  • Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, China. Electronic address: nanshi1227@shu.edu.cn.
  • Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China. Electronic address: ysheng@shu.edu.cn.
  • International Joint Laboratory of Catalytic Chemistry, Innovation Institute of Carbon Neutrality, Department of Chemistry, College of Sciences, Shanghai University, Shanghai, 200444, China. Electronic address: jmhu@shu.…

Förderung

  • Guangzhou Municipal Science and Technology Program key projects
  • National Key Research and Development Program of China
  • Science and Technology Commission of Shanghai Municipality
  • Guangdong Provincial Pearl River Talents Program
  • National Natural Science Foundation of China

Zitieren

APA

Xu, W., Lin, Y., Huang, Z., Li, Y., Lu, Y., Liu, M., Cui, S., Zhang, T., Shi, N., Sheng, Y., & Hu, J. (2026). Split proximity circuit initiated CRISPR-Cas12a system profiling exosomal surface proteins for early cancer detection. Biosensors and Bioelectronics, 295, 118280. https://doi.org/10.1016/j.bios.2025.118280

Vancouver

Xu W, Lin Y, Huang Z, Li Y, Lu Y, Liu M, et al. Split proximity circuit initiated CRISPR-Cas12a system profiling exosomal surface proteins for early cancer detection. Biosensors and Bioelectronics. 2026;295:118280. doi:10.1016/j.bios.2025.118280

BibTeX
@article{Xu2026,
  author = {Xu, Weixue and Lin, Yan and Huang, Zena and Li, Yanyan and Lu, Yao and Liu, Meiru and Cui, Sicheng and Zhang, Tenghua and Shi, Nan and Sheng, Yan and Hu, Jiaming},
  title = {Split proximity circuit initiated CRISPR-Cas12a system profiling exosomal surface proteins for early cancer detection},
  journal = {Biosensors and Bioelectronics},
  year = {2026},
  volume = {295},
  pages = {118280},
  doi = {10.1016/j.bios.2025.118280}
}
Kostenlos starten →